top of page
Search Results

214 items found for "conformational dynamics"

Programs (1)

  • Step 1

    Start off your program by giving some basic information about what participants can expect to learn.

View All

Posts (168)

  • A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...

    August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in Cell Membranes and Living Cells "Conformational biosensors to monitor the activation state of G protein-coupled We recently reported the initial characterization of a NanoBRET-based conformational histamine H3 receptor Hence, the H3R conformational biosensor in membranes might be a ready-to-use, high-throughput alternative

  • Interacting binding insights and conformational consequences of the differential activity of...

    September 2022 Interacting binding insights and conformational consequences of the differential activity Namely, CBD has been suggested to directly trigger receptor’s activation, stabilize CB1 inactive conformations From microsecond-length unbiased molecular dynamics simulations, we found that the presence of the CBD ligand in the GPR55 receptor elicit conformational changes associated with antagonist-bound GPCRs. The all-atom MD simulations reveal that CBD induces conformational changes linked with agonist-bound

  • Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs

    June 2022 "G protein-coupled receptors (GPCRs) represent a major therapeutic target class as they play a key role in many (patho-) physiological processes. GPCRs are divided into six classes based on amino acid sequence similarities, but only four of the classes (A, B, C, and F) are found in humans. GPCRs respond to a wide variety of signals that range in size from photons to proteins (Foord et al., 2005). GPCRs continue to be regarded as one of the most tractable classes of drug targets and are targeted by 30%–40% of current drugs (Hauser et al., 2017), with annual sales of GPCR-targeting drugs in 2018 accounting for >114 billion USD. In 2019, 5 out of 20 first-in-class approved therapeutic agents targeted GPCRs. Despite this high number of GPCR targeted drugs, only a small portion (∼110) of the human GPCRome (consisting of approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective small molecules remains a challenge for the remainder." Read more at the source #DrGPCR #GPCR #IndustryNews

View All

Other Pages (45)

  • AGPCR 24 Session I

    Neuroscience Institute, Institute for Biophysical Dynamics, and Center for Mechanical Excitability, The structures of a prototypical aGPCR CD97 in both inactive and active states, revealing a compact inactive conformation and significant conformational changes upon activation, particularly on the intracellular and extracellular Our findings highlight pronounced conformational shifts across the receptor, especially involving transmembrane As an undergraduate, he studied opioid receptor trafficking and G protein conformational dynamics in

  • AGPCR 24 Session V

    By structural com-parison and with the help of molecular dynamics (MD) simulations we identified several and Molecular Biology, The University of Chicago Neuroscience Institute, Institute for Biophysical Dynamics A previous computational study has uncovered variable flexible protein regions, whose dynamics mediate solvent-accessibility of the catalytically active GPS triad HL|S/T, however classical molecular dynamics of the GPS for subsequent ester hydrolysis by restricting water conformations.

  • Ep 32 with Dr. Chris Tate

    In 2005 he started working on the development of conformational thermostabilization of GPCRs, which resulted through structure determination of the β1-adrenoceptor and adenosine A2A receptor in multiple different conformations this podcast episode This short survey will help us understand your needs to bring you exciting and informative

View All
bottom of page